文献速递膀胱癌与上尿路尿路上皮癌

开放与机器人辅助根治性膀胱切除术的肿瘤学结局比较

Comparison of Oncologic Outcomes Following Open and Robotic-assisted Radical Cystectomy with both Extracorporeal and Intracorporeal Urinary Diversion.
PubMed 文献 · Urology · 2021-04-21

单中心回顾性研究纳入916例膀胱尿路上皮癌根治性膀胱切除术患者,比较开放手术与机器人辅助联合体外或体内尿流改道的肿瘤学结局。中位随访37-52个月,三组复发率与部位无差异,手术方式与生存终点无关;开放组切缘阳性率较高(7.2% vs 3.6% vs 3.2%,P=0.041)。

要点

  • 机器人辅助根治性膀胱切除术不损害长期肿瘤学结局
  • 三组复发率与复发部位无显著差异
  • 开放手术组切缘阳性率高于机器人辅助组

核心结论

  • 机器人辅助根治性膀胱切除术与开放手术相比不损害围手术期或长期肿瘤学结局。

研究设计与样本

  • 单中心回顾性研究,2010-2018年因膀胱尿路上皮癌行根治性膀胱切除术加尿流改道者共916例。
  • 开放组265例,机器人辅助联合体外尿流改道组366例,机器人辅助联合体内尿流改道组285例。

主要发现

  • 中位随访时间开放组52个月、体外组40个月、体内组37个月(P<0.001)。
  • 体内尿流改道组回肠通道术式更常见(85%,P<0.001),新辅助(p=0.4)或辅助治疗(P=0.36)、pT分期(P=0.28)或pN分期(P=0.1)无差异。
  • 软组织切缘阳性率开放组7.2%、体外组3.6%、体内组3.2%(P=0.041)。
  • 复发率或复发部位无差异;Cox比例风险模型和Kaplan-Meier分析显示手术方式与任何生存终点无关。
  • 以开放组为参照,体外组无复发生存风险比1(0.72-14),体内组0.93(0.66-1.3)。

临床怎么用

  • 机器人辅助根治性膀胱切除术可作为开放手术的替代选择,不损害肿瘤学结局。

局限性

  • 单中心回顾性研究,随访时间各组不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare oncologic endpoints between open radical cystectomy (ORC) and robotic-assisted radical cystectomy with extracorporeal urinary diversion (eRARC) or intracorporeal urinary diversion (iRARC). MATERIALS AND METHODS: Retrospective review of all patients undergoing curative-intent radical cystectomy with urinary diversion for urothelial bladder cancer at a single-institution from 2010-2018. Primary outcomes included recurrence location and rates, recurrence-free (RFS) and overall survival (OS). Survival estimates were obtained using the Kaplan-Meier method and compared using log-rank analysis. Cox proportional-hazards model was used to identify predictors of survival. RESULTS: 265, 366 and 285 patients underwent ORC, eRARC, and iRARC, respectively (n = 916). Median follow-up was 52, 40 and 37 months for ORC, eRARC and iRARC, respectively (P < 0.001). Ileal conduit was more commonly performed in iRARC (85%, P < 0.001). Neobladder rates did not vary. Neoadjuvant (p=0.4) or adjuvant therapy use (P = 0.36), pT-stage (P = 0.28) or pN-stage (P = 0.1) did not differ. Positive soft tissue margin rates were higher in ORC (7.2%-ORC, 3.6%-eRARC, 3.2%-iRARC, P = 0.041). Differences in recurrence rates or location were not observed. Surgical approach was not associated with any survival endpoint on proportional-hazards or Kaplan-Meier analysis. Hazard ratios and 95% CI for RFS were 1 (0.72-14) and 0.93 (0.66-1.3) for eRARC and iRARC, respectively, when compared to ORC as the referent. CONCLUSION: These findings from a large, single-institution in conjunction with randomized-controlled trial data suggest that RARC does not compromise perioperative or long-term oncologic outcomes when compared to ORC.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Murthy PB, Lone Z, Munoz Lopez C, et al. Comparison of Oncologic Outcomes Following Open and Robotic-assisted Radical Cystectomy with both Extracorporeal and Intracorporeal Urinary Diversion. Urology. 2021. PMID: 33891929. doi:10.1016/j.urology.2021.03.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。